SCHEMBL24012192

SCHEMBL24012192

COCCOCCOCCOc1cccc(OCCOCCOCCOC)c1N1C(=O)c2cc(Oc3ccc(S(=O)(=O)O)cc3)c3c4c(Oc5ccc(S(=O)(=O)O)cc5)cc5c6c(cc(Oc7ccc(S(=O)(=O)O)cc7)c(c7c(Oc8ccc(S(=O)(=O)O)cc8)cc(c2c37)C1=O)c64)C(=O)N(c1c(OCCOCCOCCOC)cccc1OCCOCCOCCOC)C5=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 4/20 0.34
▸ NTRK3 Q16288 4/20 0.34
▸ NTRK2 Q16620 4/20 0.34
▸ KMT2A Q03164 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HTT P42858 2/20 0.31
▸ TSHR P16473 1/20 0.31
▸ KCNJ5 P48544 2/20 0.31
▸ KCNJ3 P48549 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ DRD4 P21917 1/20 0.31
▸ DRD3 P35462 1/20 0.31
▸ MCHR1 Q99705 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ AOC2 O75106 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011813 0.88 NTRK1 (0.42) NTRK1NTRK3NTRK2KMT2AALDH1A1
SCHEMBL24011834 0.82 LMNA (0.31) KMT2AALDH1A1MEN1MAPTLMNA
SCHEMBL24011830 0.79 MAOA (0.36) —
SCHEMBL17448853 0.78 ANPEP (0.46) KMT2AALDH1A1MEN1MAPTTSHR
SCHEMBL24012143 0.77 KMT2A (0.31) KMT2AALDH1A1MEN1MAPTLMNA
SCHEMBL24011917 0.76 ANPEP (0.33) ALDH1A1TSHRSMN1; SMN2
SCHEMBL24012156 0.76 MMP9 (0.33) KMT2AALDH1A1MEN1MAPTHTT
SCHEMBL25868505 0.76 ANPEP (0.43) ALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL24011915 0.76 NR1H2 (0.39) TSHR
SCHEMBL24011958 0.75 NR1H3 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210351356-A1 IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES Konica Minolta, Inc. (JP) 2021-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210351356-A1 IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES IGF1R, IK, BMI1 NTRK1 981/4885NTRK3 2429/4885NTRK2 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback